{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T06:30:03Z","timestamp":1745303403675,"version":"3.38.0"},"reference-count":69,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fortschr Neurol Psychiatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cocaine addiction is a devastating disorder, not only for the individual but also for society. Due to the rapid increase in cocaine consumption worldwide, cocaine and its deleterious psychiatric and physical consequences have increasingly become a major focus of addiction medicine. Unfortunately, advances in the treatment of cocaine addiction cannot keep pace with the surging demand for effective, fast-acting, readily available and affordable therapies. Psychosocial and psychotherapeutic measures are still the mainstay of therapy, but many patients do not have access to or benefit sufficiently from these treatment modalities. To date, there is no pharmacotherapy that has been approved or shown to be consistently effective for cocaine addiction. Nonetheless, a fair number of promising candidate substances can be extracted from a large pool of studies and there exists enough evidence to justify the assumption that many patients are likely to benefit from at least one of these substances. We have thoroughly analyzed the literature and contributed our own research results in order to integrate clinically relevant findings into an algorithm that enables the clinician to make the current state of knowledge usable in routine practice. <\/jats:p>","DOI":"10.1055\/a-2537-9595","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:48:31Z","timestamp":1741740511000},"source":"Crossref","is-referenced-by-count":1,"title":["Flimsy but handy: Devising an algorithm as a novel approach to the pharmacotherapy of cocaine addiction"],"prefix":"10.1055","author":[{"given":"Sebastian Karl Maximilian","family":"Fischer","sequence":"additional","affiliation":[{"name":"Psychiatric Services Lucerne, Lucerne, Switzerland"},{"name":"Institute of General Practice and Family Medicine, Ludwig Maximilian University of Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Mutschler","sequence":"additional","affiliation":[{"name":"Psychiatric Services Lucerne, Lucerne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"ref1","volume-title":"European Drug Report. Trends and Developments","author":"EMCDDA \u2013 European Monitoring Centre for Drugs and Drug Addiction","year":"2023"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2486\/indhealth.2021-0159","article-title":"Increasing cocaine use amongst employed Australians: who is most at-risk?","volume":"60","author":"A McEntee","year":"2022","journal-title":"Ind Health"},{"key":"ref3","first-page":"106950","article-title":"Trends and correlates of cocaine use among adutls in the United States, 2002\u20132019","volume":"120","author":"D Mustaquim","year":"2021","journal-title":"Addict Behav"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"D Nutt","year":"2007","journal-title":"Lancet"},{"key":"ref5","volume-title":"World Drug Report","author":"UNODOC","year":"2023"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"102227","DOI":"10.1016\/j.pmedr.2023.102227","article-title":"Intentional use of both opioids and cocaine in the United States","volume":"33","author":"X Liu","year":"2023","journal-title":"Prev Med Rep"},{"key":"ref7","volume-title":"Illicit Drug Use","author":"AIHW \u2013 Australian Institute of Health and Welfare","year":"2023"},{"key":"ref8","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health","author":"SAMHSA","year":"2021"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(01)00367-0","article-title":"From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol","volume":"26","author":"F A Wagner","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e218049","DOI":"10.1001\/jamanetworkopen.2021.8049","article-title":"Comparison of treatments for cocaine use disorder among adults: a systematic review and meta-analysis","volume":"4","author":"B S Bentzley","year":"2021","journal-title":"JAMA Network Open"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2015.01.002","article-title":"Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: a comprehensive narrative overview of English-language studies","volume":"26","author":"B Fischer","year":"2015","journal-title":"Int J Drug Policy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"eaax1532","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"K M Kampman","year":"2019","journal-title":"Sci Adv"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use disorder: a systematic review and meta-analysis","volume":"34","author":"B Chan","year":"2019","journal-title":"J Gen Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/add.15242","article-title":"Pharmacotherapeutic strategies for treating cocaine use \u2013 what do we have to offer?","volume":"116","author":"L Brandt","year":"2021","journal-title":"Addiction"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/brainsci12111546","article-title":"Pharmacological treatments for cocaine craving: what is the way forward? A systematic review","volume":"12","author":"DL S Lassi","year":"2022","journal-title":"Brain Sci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000531008","article-title":"Concomitant drug use among opioid-dependent patients with and without attention deficit hyperactivity disorder: does methylphenidate merit a trial?","volume":"29","author":"L Tschudi","year":"2023","journal-title":"Eur Addict Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/ADM.0000000000000193","article-title":"A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction","volume":"10","author":"K Dugosh","year":"2016","journal-title":"J Addict Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2022.0395","article-title":"Treatment of tobacco smoking: a review","volume":"327","author":"N A Rigotti","year":"2022","journal-title":"JAMA"},{"key":"ref20","first-page":"CD007380","article-title":"Psychostimulant drugs for cocaine dependence","volume":"9","author":"X Castells","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00213-020-05563-3","article-title":"Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis","volume":"237","author":"V S Tardelli","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"S V Faraone","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/npp.2012.17","article-title":"Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate","volume":"37","author":"M J Ferris","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jama.286.8.905","article-title":"Pay attention: ritalin acts much like cocaine","volume":"286","author":"B Vastag","year":"2001","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1002715","DOI":"10.1371\/journal.pmed.1002715","article-title":"Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis","volume":"15","author":"F De Crescenzo","year":"2018","journal-title":"PLoS Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/SAR.S50807","article-title":"Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence","volume":"6","author":"K M D\u00fcrsteler","year":"2015","journal-title":"Subst Abuse Rehabil"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JCP.0b013e31827bfff4","article-title":"A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription","volume":"33","author":"K M D\u00fcrsteler-McFarland","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","article-title":"Replacement medication for cocaine dependence: methylphenidate","volume":"17","author":"J Grabowski","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2006.07.004","article-title":"Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo","volume":"87","author":"F R Levin","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1037\/1064-1297.10.3.286","article-title":"Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence","volume":"10","author":"H Schubiner","year":"2002","journal-title":"Exp Clin Psychopharmacol"},{"key":"ref34","volume-title":"Attention deficit hyperactivity disorder: diagnosis and mangement","author":"NICE \u2013 National Institute for Health and Care Excellence","year":"2019"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/mp.2008.90","article-title":"Potential adverse effects of amphetamine treatment on brain and behavior: a review","volume":"14","author":"S M Berman","year":"2009","journal-title":"Mol Psychiatry"},{"key":"ref36","first-page":"389","article-title":"Treatment of adults with attention-deficit\/hyperactivity disorder","volume":"4","author":"D Kolar","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","article-title":"Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial","volume":"387","author":"M Nuijten","year":"2016","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/add.14874","article-title":"Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial","volume":"115","author":"P Blanken","year":"2020","journal-title":"Addiction"},{"key":"ref39","first-page":"CD007813","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults","volume":"8","author":"X Castells","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s15005-023-3315-7","article-title":"Diagnostik und Therapie der ADHS im Erwachsenenalter","volume":"25","author":"M K\u00f6lle","year":"2023","journal-title":"InFo Neurologie & Psychiatrie"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/00952990.2021.1885677","article-title":"Open-label pilot study of lisdexamfetamine for cocaine use disorder","volume":"47","author":"J J Mariani","year":"2021","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2015.05.042","article-title":"Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial","volume":"153","author":"M E Mooney","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"ref43","first-page":"293","article-title":"A review of modafinil film-coated tablets for attention-deficit\/hyperactivity disorder in children and adolescents","volume":"3","author":"T Rugino","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1586\/14737175.6.4.455","article-title":"A review of the use of modafinil for attention-deficit hyperactivity disorder","volume":"6","author":"D Turner","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1192\/apt.bp.111.009340","article-title":"ADHD with comorbid substance use disorder: review of treatment","volume":"18","author":"R Magon","year":"2012","journal-title":"Adv Psychiatr Treat"},{"key":"ref46","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"P Gerrard","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1369-1600.2012.00506.x","article-title":"Modafinil attenuates reinstatement of cocaine seeking: role for cystine-glutamate exchange and metabotropic glutamate receptors","volume":"19","author":"S V Mahler","year":"2014","journal-title":"Addict Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fneur.2013.00139","article-title":"Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions","volume":"4","author":"J Wisor","year":"2013","journal-title":"Front Neurol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"A L Anderson","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"110958","DOI":"10.1016\/j.drugalcdep.2023.110958","article-title":"Potential effect of antidepressants on remission from cocaine use disorder \u2013 A nationwide matched retrospective cohort study","volume":"251","author":"Z Gao","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"ref51","first-page":"52","article-title":"Bupropion: off-label treatment for cocaine and methamphetamine addiction","volume":"9","author":"H B Magyar","year":"2010","journal-title":"Current Psychiatry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1570159X13666150729222643","article-title":"The role of topiramate in the management of cocaine addiction: a possible therapeutic option","volume":"13","author":"A Siniscalchi","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1345\/aph.10093","article-title":"Topiramate titration and tolerability","volume":"35","author":"Topiramate TPS-TR Study Group","year":"2001","journal-title":"Ann Pharmacother"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"H R Kranzler","year":"2018","journal-title":"JAMA"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ADM.0000000000000443","article-title":"Topiramate pharmacotherapy for alcohol use disorder and other addictions: a narrative review","volume":"13","author":"A Manhapra","year":"2019","journal-title":"J Addict Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/add.13974","article-title":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate","volume":"113","author":"C Palpacuer","year":"2018","journal-title":"Addiction"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-3223(97)00426-5","article-title":"Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone \u2013 a multiple-dose study","volume":"44","author":"E F McCance-Katz","year":"1998","journal-title":"Biol Psychiatry"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00115-005-2044-0","article-title":"Neue Entwicklungen in der Pharmakotherapie der Kokainabh\u00e4ngigkeit","volume":"77","author":"G Wiesbeck","year":"2006","journal-title":"Nervenarzt"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1360-0443.2002.00158.x","article-title":"Effects of concurrent use of alcohol and cocaine","volume":"97","author":"EJ M Pennings","year":"2002","journal-title":"Addiction"},{"key":"ref61","first-page":"e22498","article-title":"Cocaethylene: when cocaine and alcohol are taken together","volume":"14","author":"J Pergolizzi","year":"2022","journal-title":"Cureus"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mi.9.4.6","article-title":"Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse","volume":"9","author":"M Gaval-Cruz","year":"2009","journal-title":"Mol Interv"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/JCP.0b013e3181934451","article-title":"Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action","volume":"29","author":"J Mutschler","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0042-103592","article-title":"Current findings and mechanisms of action of disulfiram in the treatment of alcohol dependence","volume":"49","author":"J Mutschler","year":"2016","journal-title":"Pharmacopsychiatry"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/YCO.0000000000000518","article-title":"Medications to treat cocaine use disorders: current options","volume":"32","author":"J Buchholz","year":"2019","journal-title":"Curr Opin Psychiatry"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"854176","DOI":"10.3389\/fphar.2022.854176","article-title":"A mechanistic overview of approaches for the treatment of psychostimulant dependence","volume":"13","author":"K L Jensen","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref67","first-page":"CD007024","article-title":"Disulfiram for the treatment of cocaine dependence","volume":"1","author":"P P Pani","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"I L Petrakis","year":"2000","journal-title":"Addiction"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"L Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"ref70","first-page":"748","article-title":"Toward addiction prediction: An overview of cross-validated predictive modeling findings and considerations for future neuroimaging research","volume":"5","author":"S W Yip","year":"2020","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12888-015-0383-3","article-title":"Natural course of behavioral addictions: a 5-year longitudinal study","volume":"15","author":"B K Thege","year":"2015","journal-title":"BMC Psychiatry"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/10678281003634975","article-title":"Trajectories of substance use disorders in youth: identifying and predicting group memberships","volume":"19","author":"CY S Lee","year":"2010","journal-title":"J Child Adolesc Subst Abuse"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.pnpbp.2007.08.040","article-title":"The effects of cocaine: a shifting target over the course of addiction","volume":"31","author":"L J Porrino","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ijnp\/pyx043","article-title":"How effective is algorithm-guided treatment for depressed inpatients? Results from the randomized controlled multicenter German Algorithm Project 3 Trial","volume":"20","author":"M Adli","year":"2017","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["Fortschritte der Neurologie \u00b7 Psychiatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2537-9595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:48:59Z","timestamp":1741740539000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2537-9595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":69,"URL":"https:\/\/doi.org\/10.1055\/a-2537-9595","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-4299","1439-3522"],"issn-type":[{"value":"0720-4299","type":"print"},{"value":"1439-3522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}